PCVX
Closed
Vaxcyte inc
32.94
+0.43 (+1.32%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 32.51
Day's Range: 32. - 34.6285
Send
sign up or login to leave a comment!
When Written:
34.66
Vaxcyte Inc is a clinical-stage biotechnology company that focuses on the development of vaccines for infectious diseases. The company was founded in 2018 and is headquartered in Foster City, California. Vaxcyte's lead product candidate, VAX-24, is a protein-based vaccine designed to protect against pneumococcal disease, a leading cause of bacterial pneumonia, meningitis, and sepsis. The company's pipeline also includes vaccine candidates for group A streptococcus and Lyme disease. Vaxcyte has partnerships with several organizations, including the Bill and Melinda Gates Foundation, the National Institute of Allergy and Infectious Diseases, and the Coalition for Epidemic Preparedness Innovations. The company went public in June 2020, raising $250 million in its initial public offering.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








